bioAffinity Technologies, Inc. (BIAF)
9.93
-0.57
(-5.43%)
USD |
NASDAQ |
Sep 10, 13:28
bioAffinity Technologies Total Assets (Quarterly) : 7.619M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.619M |
| March 31, 2026 | 7.945M |
| December 31, 2025 | 10.96M |
| September 30, 2025 | 11.55M |
| June 30, 2025 | 4.751M |
| March 31, 2025 | 5.547M |
| December 31, 2024 | 6.514M |
| September 30, 2024 | 6.552M |
| June 30, 2024 | 6.656M |
| March 31, 2024 | 8.049M |
| December 31, 2023 | 8.222M |
| September 30, 2023 | 10.19M |
| Date | Value |
|---|---|
| June 30, 2023 | 8.874M |
| March 31, 2023 | 10.46M |
| December 31, 2022 | 12.18M |
| September 30, 2022 | 14.06M |
| June 30, 2022 | 0.9407M |
| March 31, 2022 | 1.353M |
| December 31, 2021 | 1.453M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.1456M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| Veracyte, Inc. | 1.486B |
| ABVC BioPharma, Inc. | 19.40M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.850M |
| Shareholders Equity (Quarterly) | 3.769M |
| Debt to Equity Ratio | 0.3808 |
| Current Ratio | 1.442 |
| Net Debt Paydown Yield | -0.38% |